Loading...
Immunic, Inc.
IMUX•NASDAQ
HealthcareBiotechnology
$0.79
$0.02(2.005%)
Immunic, Inc. (IMUX) Financial Performance & Statements
Review Immunic, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
1.18%
↑ 1.18%
Net Income Growth
-7.37%
↓ 7.37%
Operating Cash Flow Growth
-19.68%
↓ 19.68%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-326.95%
↓ 326.95%
ROIC
1989.29%
↑ 1989.29%
Immunic, Inc. (IMUX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Immunic, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $31000.00 | $26000.00 |
| Gross Profit | $0.00 | $0.00 | -$31000.00 | -$26000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $21.62M | $21.37M | $18.32M | $18.74M |
| SG&A Expenses | $4.01M | $4.36M | $4.46M | $5.12M |
| Operating Expenses | $25.63M | $25.73M | $22.78M | $23.86M |
| Total Costs & Expenses | $25.63M | $25.73M | $22.81M | $23.88M |
| Interest Income | $429000.00 | $776000.00 | $998000.00 | $1.19M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $35000.00 | $42000.00 | $31000.00 | $26000.00 |
| EBITDA | -$25.60M | -$25.68M | -$22.78M | -$23.86M |
| EBITDA Ratio | ||||
| Operating Income | -$25.63M | -$25.73M | -$22.81M | -$23.88M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $456000.00 | $1.36M | $1.43M | -$5.70M |
| Income Before Tax | -$25.18M | -$24.37M | -$21.38M | -$29.58M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$17276.00 |
| Net Income | -$25.18M | -$24.37M | -$21.38M | -$29.58M |
| Net Income Ratio | ||||
| EPS | -$0.25 | -$0.24 | -$0.21 | -$0.30 |
| Diluted EPS | -$0.25 | -$0.24 | -$0.21 | -$0.30 |
| Weighted Avg Shares Outstanding | $90.15M | $101.27M | $101.27M | $97.30M |
| Weighted Avg Shares Outstanding (Diluted) | $90.15M | $101.27M | $101.27M | $97.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan